In Episode 4, Dr Dennis Wright, CLINUVEL’s Chief Scientific Officer discussed the development history and regulatory work that led to the approval of our drug.
This episode, we welcome Dr Azza Hamila, CLINUVEL’s Head of Quality and Drug Safety, to discuss the importance of pharmacovigilance—the essential, ongoing system that constantly monitors and evaluates the safety profile of a drug once it is in wider use.
Dr Hamila explains the science behind risk management, the methods we use to quickly detect new safety issues, and the proactive measures taken to protect patients. Learn about the processes put in place to ensure that a drug remains safe and effective throughout its entire lifecycle.